|
US1354753A
(en)
|
1919-02-11 |
1920-10-05 |
E M Lannes |
Portable building
|
|
US2180006A
(en)
|
1936-09-09 |
1939-11-14 |
Eastman Kodak Co |
Process for the separation and refining of amines
|
|
GB891817A
(en)
|
1959-04-07 |
1962-03-21 |
Upjohn Co |
Improvements in or relating to injectable tetracyclic preparations
|
|
US3843787A
(en)
|
1969-01-15 |
1974-10-22 |
Pierrel Spa |
Water soluble derivative of erythromycin
|
|
US3668282A
(en)
|
1970-05-08 |
1972-06-06 |
Stauffer Chemical Co |
Stabilized mixture employing n-(beta-0,0-dialkyldithiophosphoryl) aryl sulfonamides
|
|
SE458505B
(sv)
|
1979-07-10 |
1989-04-10 |
Lepetit Spa |
Anvaendningen av rifamycin sv och salter daerav foer framstaellning av en beredning foer behandling av reumatoid artrit samt vissa av salterna och deras framstaellning
|
|
US4331803A
(en)
|
1980-06-04 |
1982-05-25 |
Taisho Pharmaceutical Co., Ltd. |
Novel erythromycin compounds
|
|
US4474768A
(en)
|
1982-07-19 |
1984-10-02 |
Pfizer Inc. |
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
|
|
JPS59175414A
(ja)
|
1983-03-23 |
1984-10-04 |
Toyo Jozo Co Ltd |
マクロライド抗生物質の安定な経口用製剤および安定化法
|
|
US4742049A
(en)
|
1986-06-04 |
1988-05-03 |
Abbott Laboratories |
Semisynthetic erythromycin antibiotics
|
|
KR960000434B1
(ko)
|
1986-12-17 |
1996-01-06 |
다이쇼 세이야꾸 가부시끼가이샤 |
에리스로마이신 a유도체 및 그의 제조 방법
|
|
DE3860503D1
(de)
|
1987-09-03 |
1990-10-04 |
Pliva Pharm & Chem Works |
10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
|
|
BE1001869A3
(fr)
|
1988-10-12 |
1990-04-03 |
Franz Legros |
Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
|
|
IL99995A
(en)
|
1990-11-21 |
1997-11-20 |
Roussel Uclaf |
Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
|
|
US5985844A
(en)
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
|
US5527780A
(en)
|
1992-11-05 |
1996-06-18 |
Roussel Uclaf |
Erythromycin derivatives
|
|
FR2697524B1
(fr)
|
1992-11-05 |
1994-12-23 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
FR2718450B1
(fr)
|
1994-04-08 |
1997-01-10 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
FR2719587B1
(fr)
|
1994-05-03 |
1996-07-12 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
US5968977A
(en)
*
|
1995-06-28 |
1999-10-19 |
Tokuyama Corporation |
Ketonitrile derivatives and antibacterial agent and drugs containing the same
|
|
FR2739620B1
(fr)
|
1995-10-09 |
1997-12-19 |
Roussel Uclaf |
Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
|
|
US6274715B1
(en)
|
1995-11-08 |
2001-08-14 |
Abbott Laboratories |
Tricyclic erythromycin derivatives
|
|
US5742049A
(en)
*
|
1995-12-21 |
1998-04-21 |
Bruker-Franzen Analytik Gmbh |
Method of improving mass resolution in time-of-flight mass spectrometry
|
|
FR2742757B1
(fr)
|
1995-12-22 |
1998-01-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
FR2745290B1
(fr)
|
1996-02-28 |
1998-04-03 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
US5719272A
(en)
|
1996-04-02 |
1998-02-17 |
Abbott Laboratories |
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
|
|
ATE296831T1
(de)
|
1996-09-04 |
2005-06-15 |
Abbott Lab |
6-0-substituierte ketoliden mit antibakteriellen wirkung
|
|
EP0944594A4
(en)
|
1996-12-13 |
2000-05-03 |
Lilly Co Eli |
INHIBITORS OF THE PSA ANTIGEN ENZYMATIC ACTIVITY
|
|
HN1998000086A
(es)
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
|
US6407074B1
(en)
|
1997-06-11 |
2002-06-18 |
Pfizer Inc |
C-4″-substituted macrolide derivatives
|
|
EP0988308A1
(en)
|
1997-06-11 |
2000-03-29 |
Pfizer Products Inc. |
9-oxime erythromycin derivatives
|
|
HN1998000074A
(es)
|
1997-06-11 |
1999-01-08 |
Pfizer Prod Inc |
Derivados de macrolidos c-4 sustituidos
|
|
HN1998000159A
(es)
|
1997-10-29 |
1999-02-09 |
Monsanto Co |
Derivados de 9- amino - 3 ceto eritromicina
|
|
IL135792A0
(en)
|
1997-12-01 |
2001-05-20 |
Abbott Lab |
6-o-alkyl derivatives of erythronolide b
|
|
KR100440553B1
(ko)
*
|
1998-03-26 |
2004-07-15 |
후지사와 야꾸힝 고교 가부시키가이샤 |
서방성 제제
|
|
FR2777282B1
(fr)
|
1998-04-08 |
2001-04-20 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
|
|
US6387885B1
(en)
|
1998-08-26 |
2002-05-14 |
Abbott Laboratories |
3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
|
|
US6020521A
(en)
|
1998-08-26 |
2000-02-01 |
Abbott Laboratories |
Macrolide LHRH antagonists
|
|
FR2785612A1
(fr)
|
1998-11-10 |
2000-05-12 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
KR100317907B1
(ko)
|
1998-11-24 |
2001-12-24 |
김 완 주 |
신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
|
|
FR2786188B1
(fr)
|
1998-11-24 |
2002-10-31 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
|
|
EP1137654A1
(en)
|
1998-12-10 |
2001-10-04 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
|
AP2001002222A0
(en)
|
1999-01-27 |
2001-09-30 |
Pfizer Prod Inc |
Ketolide antibiotics.
|
|
CA2411293A1
(en)
|
1999-01-28 |
2000-07-28 |
Pfizer Products Inc. |
Novel azalides and methods of making same
|
|
FR2789392B1
(fr)
|
1999-02-04 |
2001-10-05 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
AR023264A1
(es)
|
1999-04-08 |
2002-09-04 |
Hokuriku Pharmaceutical |
Derivados de eritromicina
|
|
JP2000351794A
(ja)
|
1999-04-08 |
2000-12-19 |
Hokuriku Seiyaku Co Ltd |
エリスロマイシン誘導体
|
|
JP2002542197A
(ja)
|
1999-04-16 |
2002-12-10 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
ケトライド抗菌剤
|
|
AU775637B2
(en)
|
1999-04-16 |
2004-08-12 |
Kosan Biosciences, Inc. |
Macrolide antiinfective agents
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6420535B1
(en)
|
1999-06-07 |
2002-07-16 |
Abbott Laboratories |
6-O-carbamate ketolide derivatives
|
|
US6437106B1
(en)
|
1999-06-24 |
2002-08-20 |
Abbott Laboratories |
Process for preparing 6-o-substituted erythromycin derivatives
|
|
AU6183700A
(en)
|
1999-08-06 |
2001-03-05 |
Taisho Pharmaceutical Co., Ltd. |
Erythromycin a derivatives
|
|
WO2001010787A1
(en)
|
1999-08-09 |
2001-02-15 |
Eric Au |
An apparatus for treating wastewater
|
|
US6096922A
(en)
|
1999-11-01 |
2000-08-01 |
Air Products And Chemicals, Inc. |
Process for the synthesis of dialkyl, diaryl, and arylalkyl aminosulfur trifluorides
|
|
KR100336447B1
(ko)
|
1999-11-24 |
2002-05-15 |
민경윤 |
클라리스로마이신의 개선된 제조방법
|
|
JP2001261694A
(ja)
|
2000-03-06 |
2001-09-26 |
Pfizer Prod Inc |
ケトライド抗生物質
|
|
MXPA02008861A
(es)
|
2000-03-15 |
2003-02-10 |
Hanmi Pharm Ind Co Ltd |
Metodo para preparar claritromicina de cristales de forma ii.
|
|
NZ523693A
(en)
|
2000-07-10 |
2004-08-27 |
Chiron Corp |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
|
US20020115621A1
(en)
*
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
|
GB0031312D0
(en)
|
2000-12-21 |
2001-02-07 |
Glaxo Group Ltd |
Macrolides
|
|
US20030143162A1
(en)
|
2001-05-18 |
2003-07-31 |
Speirs Robert John |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
|
|
JP4509553B2
(ja)
|
2001-07-03 |
2010-07-21 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
抗菌活性を有するｃ１２修飾エリスロマイシンマクロライドおよびケトライド
|
|
US20030176327A1
(en)
*
|
2001-10-25 |
2003-09-18 |
Cassell Gail Houston |
Antibiotics for treating biohazardous bacterial agents
|
|
MXPA04008173A
(es)
|
2002-02-22 |
2004-11-26 |
Pharmacia Corp |
Formulaciones de farmaco antibiotico oftalmico que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio.
|
|
ES2566761T3
(es)
|
2002-05-30 |
2016-04-15 |
The Scripps Research Institute |
Ligación de azidas y acetilenos catalizada por cobre
|
|
WO2003105775A2
(en)
|
2002-06-17 |
2003-12-24 |
Epigenesis Pharmaceuticals, Inc. |
Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
|
|
JP4790263B2
(ja)
|
2002-07-08 |
2011-10-12 |
グラクソ グループ リミテッド |
炎症性の疾患および病態を治療する新規な化合物、組成物および方法
|
|
TW200420573A
(en)
|
2002-09-26 |
2004-10-16 |
Rib X Pharmaceuticals Inc |
Bifunctional heterocyclic compounds and methods of making and using same
|
|
ITMI20022292A1
(it)
|
2002-10-29 |
2004-04-30 |
Zambon Spa |
9a-azalidi ad attivita' antiinfiammatoria.
|
|
EP3738591A3
(en)
*
|
2003-03-10 |
2021-03-24 |
Merck Sharp & Dohme Corp. |
Novel antibacterial agents
|
|
CA2523134A1
(en)
|
2003-04-25 |
2004-11-11 |
Chiron Corporation |
Pyridyl substituted ketolide antibiotics
|
|
US7163924B2
(en)
|
2003-04-25 |
2007-01-16 |
Chiron Corporation |
Ketolide derivatives
|
|
DK1628989T3
(da)
|
2003-05-13 |
2007-10-08 |
Glaxo Group Ltd |
Hidtil ukendte, 14- og 15-leddet ring-forbindelser
|
|
WO2005007143A2
(en)
|
2003-07-14 |
2005-01-27 |
The Board Of Trustees Of The University Of Illinois |
Use of makrolides and ketolides for the treatment of tuberculosis
|
|
US7457520B2
(en)
|
2003-07-24 |
2008-11-25 |
Time Warner Cable, Inc. |
Technique for providing a virtual digital video recorder service through a communications network
|
|
GB0402578D0
(en)
|
2004-02-05 |
2004-03-10 |
Cambridge Theranostics Ltd |
Methods of treatment of atherosclerosis
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US20060116336A1
(en)
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
|
ATE373009T1
(de)
|
2004-04-28 |
2007-09-15 |
Alembic Ltd |
Verfahren zur vorbereitung von telithromycin
|
|
CA2566085A1
(en)
|
2004-05-06 |
2005-11-17 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O |
Ester linked macrolides useful for the treatment of microbial infections
|
|
BRPI0513903A
(pt)
|
2004-07-28 |
2008-05-20 |
Ranbaxy Lab Ltd |
derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos
|
|
GB0424959D0
(en)
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0424958D0
(en)
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2006106440A1
(en)
|
2005-01-14 |
2006-10-12 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
Macrolide compounds containing biotin and photo-affinity group for macrolide target identification
|
|
EP1841437B1
(en)
|
2005-01-14 |
2009-04-29 |
GlaxoSmithKline istrazivacki centar Zagreb d.o.o. |
9a-carbamoyl and thiocarbamoyl azalides with antimalarial activity
|
|
EP1835921B1
(en)
|
2005-01-14 |
2010-08-18 |
GlaxoSmithKline istrazivacki centar Zagreb d.o.o. |
9a-carbamoyl-y-aminopropyl- and 9a-thiocarbamoyl-y-aminopropyl-azalides with antimalarial activity
|
|
WO2006102283A2
(en)
|
2005-03-22 |
2006-09-28 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamylalkanoic acids for treating premenstrual disorders
|
|
CA2614412A1
(en)
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
|
PL1910346T3
(pl)
|
2005-07-19 |
2019-09-30 |
Azevan Pharmaceuticals, Inc. |
Beta-laktamowy antagonista wazopresyny fenyloalaniny, cysteiny i seryny
|
|
MY148124A
(en)
|
2005-10-31 |
2013-02-28 |
Leo Pharma As |
Preparation of a crystalline antibiotic substance
|
|
GB0522715D0
(en)
|
2005-11-08 |
2005-12-14 |
Helperby Therapeutics Ltd |
New use
|
|
WO2007059307A2
(en)
|
2005-11-15 |
2007-05-24 |
Teva Pharmaceutical Industries Ltd. |
Crystalline and amorphous forms of telithromycin
|
|
US20090075916A1
(en)
|
2005-11-23 |
2009-03-19 |
Upadhyay Dilip J |
Use of Macrolide Derivatives for Treating Acne
|
|
WO2007060518A2
(en)
*
|
2005-11-23 |
2007-05-31 |
Ranbaxy Laboratories Limited |
Ketolide derivatives as antibacterial agents
|
|
DOP2006000268A
(es)
*
|
2005-12-22 |
2007-07-31 |
Pfizer Prod Inc |
Agentes antibacterianos
|
|
CN101045063B
(zh)
|
2006-03-28 |
2011-01-26 |
广州朗圣药业有限公司 |
注射用克拉霉素水溶性制剂
|
|
CN103193840A
(zh)
|
2006-05-01 |
2013-07-10 |
大正制药株式会社 |
大环内酯衍生物
|
|
JP2009539866A
(ja)
|
2006-06-05 |
2009-11-19 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換エリスロマイシンアナログの調製および有用性
|
|
DE102006036199B4
(de)
*
|
2006-08-03 |
2016-01-07 |
Deere & Company |
Förderzusammenbau und Presse
|
|
CN101129383B
(zh)
|
2006-08-25 |
2014-04-02 |
天津和美生物技术有限公司 |
含氨基糖苷类抗生素的抗生素复方
|
|
CN101917850B
(zh)
|
2007-10-25 |
2016-01-13 |
森普拉制药公司 |
大环内酯类抗菌剂的制备方法
|
|
US20090209547A1
(en)
*
|
2008-02-15 |
2009-08-20 |
In Jong Kim |
C-8 halogenated macrolides
|
|
DK2358379T3
(en)
|
2008-10-24 |
2016-03-07 |
Cempra Pharmaceuticals Inc |
BIOFORSVAR USING TRIAZOLHOLDIGE macrolides
|
|
US9814657B2
(en)
|
2009-04-27 |
2017-11-14 |
Premier Dental Products Company |
Buffered microencapsulated compositions and methods
|
|
CA2767614C
(en)
|
2009-07-13 |
2019-01-15 |
Cempra Pharmaceuticals Inc. |
Fusidic acid dosing regimens for treatment of bacterial infections
|
|
EP2475253B1
(en)
|
2009-09-10 |
2016-10-26 |
Cempra Pharmaceuticals, Inc. |
Methods for treating malaria, tuberculosis and mac diseases
|
|
US20110119604A1
(en)
|
2009-11-19 |
2011-05-19 |
Clevest Solutions Inc. |
System and method for a configurable and extensible allocation and scheduling tool
|
|
JP5890785B2
(ja)
|
2010-03-10 |
2016-03-22 |
センプラ ファーマシューティカルズ，インコーポレイテッド |
マクロライド抗生物質の非経口製剤
|
|
BR112012023950A2
(pt)
|
2010-03-22 |
2016-07-05 |
Cempra Pharmaceuticals Inc |
formas cristalinas de um macrolídeo, e usos dos mesmos
|
|
PL2571506T3
(pl)
|
2010-05-20 |
2017-10-31 |
Cempra Pharmaceuticals Inc |
Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich
|
|
US8247394B2
(en)
|
2010-06-02 |
2012-08-21 |
Cempra Pharmaceuticals Inc. |
Methods of treating urethritis and related infections using fusidic acid
|
|
WO2012012257A2
(en)
|
2010-07-19 |
2012-01-26 |
Virginia Commonwealth University |
BIVALENT MULTIFUNCTIONAL LIGANDS TARGETING Aβ OLIGOMERS AS TREATMENT FOR ALZHEIMER'S DISEASE
|
|
US20130164351A1
(en)
|
2010-08-30 |
2013-06-27 |
Cempra Pharmaceuticals Inc. |
Methods of treating bacterial infections through pulmonary delivery of fusidic acid
|
|
US9815863B2
(en)
|
2010-09-10 |
2017-11-14 |
Cempra Pharmaceuticals, Inc. |
Hydrogen bond forming fluoro ketolides for treating diseases
|
|
WO2012042534A2
(en)
|
2010-09-28 |
2012-04-05 |
Glenmark Generics Limited |
Processes for the preparation of r-sitagliptin and intermediates thereof
|
|
WO2012162439A2
(en)
|
2011-05-23 |
2012-11-29 |
Cem-102 Pharmaceuticals, Inc. |
Compositions comprising fusidic acid and packages therefor
|
|
JP5666743B2
(ja)
|
2011-08-27 |
2015-02-12 |
ウォックハート リミテッド |
１，６−ジアザビシクロ［３，２，１］オクタン−７−オン誘導体および細菌感染の処置におけるそれらの使用
|
|
CN103998442B
(zh)
|
2011-08-29 |
2016-09-14 |
无限药品股份有限公司 |
杂环化合物及其用途
|
|
WO2013059610A1
(en)
|
2011-10-20 |
2013-04-25 |
Trius Therapeutics, Inc. |
Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
|
|
MX2014011537A
(es)
|
2012-03-27 |
2015-02-10 |
Cempra Pharmaceuticals Inc |
Formulaciones parenterales para la administracion de antibioticos macrolidos.
|
|
WO2014152326A1
(en)
|
2013-03-14 |
2014-09-25 |
Cempra Pharmaceuticals, Inc. |
Methods for treating respiratory diseases and formulations therefor
|
|
BR112015023670A2
(pt)
|
2013-03-15 |
2017-07-18 |
Cempra Pharmaceuticals Inc |
processo para preparar um composto
|
|
BR112015025159A2
(pt)
|
2013-04-04 |
2017-07-18 |
Harvard College |
macrolídeos e métodos de sua preparação e uso
|
|
CA2939076A1
(en)
|
2014-02-14 |
2015-08-20 |
Cempra Pharmaceuticals, Inc. |
Compositions and methods for treating diabetes and liver diseases
|
|
WO2015181723A1
(en)
|
2014-05-27 |
2015-12-03 |
Dipharma Francis S.R.L. |
Azidoalkylamine salts and their use as intermediates
|
|
US20170224664A1
(en)
|
2014-08-05 |
2017-08-10 |
Cempra Pharmaceuticals, Inc. |
Powder oral suspension formulations of antibacterial agents
|
|
US20180044365A1
(en)
|
2015-03-06 |
2018-02-15 |
Cempra Pharmaceuticals, Inc. |
Processes for preparing fluoroketolides
|